Bang, Chul Hwan, et al. “Ustekinumab Demonstrates Lower Uveitis Risk in Moderate to Severe Psoriasis Patients Compared With Tumor Necrosis Factor-α Inhibitors”. Acta Dermato-Venereologica, vol. 104, Sept. 2024, p. adv34206, doi:10.2340/actadv.v104.34206.